The Navicor Group LLC 2014

,

480 Olde Worthington Road, Suite 200
Westerville, OH 43082
Telephone: 614-543-6011
Facsimile: 614-739-8330
E-mail: [email protected]
Website: navicorgroup.com

Quick Facts

Accounts  
Account wins 8
Account losses 1
Accounts resigned 1
Active business clients 12
Brands by 2013 sales  
Brand-product accounts held 16
$25 million or less 1
$25 million – $50 million 2
$50 million – $100 million 1
$100 million – $500 million 4
Services Mix  
Product promotion 40%
Digital 25%
Conventions 15%
Disease awarenessg 15%
Branding 5%

Client Roster

Amag
Cadence
Incyte
Millennium: The Takeda Oncology
Company
NanoString
OncoGenex
OSUCCC
Regeneron/Sanofi
Seattle Genetics
Sigma-Tau
Sunesis
Synta
Takeda
Teva Oncology

Navicor is heading into its tenth year, yet an agency that specializes in just one therapeutic area is still a novel idea. Started with the passion of one man, Garnett Dezember, and brought to life by those who decided to follow his vision, Navicor continues to stand alone as the only oncology agency.

The Year’s Accomplishments

For Navicor, 2013 will be a year to remember, executives say. Navicor was honored as Med Ad News’ Agency of the Year, Category III, and then the creative awards just kept coming – 43 in total. All in all, Navicor was recognized for its creativity, digital expertise, and innovations. Navicor leveraged these accomplishments with a continued, strong business development push, resulting in six new clients and a 75 percent win rate, according to agency leadership.

“The health of an agency requires balance,” says President Dave Querry. “New business and prospecting is the lifeblood of the agency long-term, but you also need to maintain the focus and deliver strategic insights, ideas, and innovation to your current clients. Simply hiring a person with oncology listed in his or her resume is not enough. At Navicor, oncology is a passion and focus – something for which clients have been seeking and something we are bullish on growing.”

Navicor expanded its client roster with Amag Pharmaceuticals for work on both Feraheme and MuGard; Regeneron and Sanofi for work on Zaltrap; Synta for the launch of ganetespib; Incyte for an indication expansion of Jakafi; and Cadence to develop its interactive visual aid for Ofirmev. The agency also branched into new sectors, adding The Ohio State University Comprehensive Cancer Center-Arthur G James Cancer Hospital and Richard J. Solove Research Institute (The James) as its first business-to-business client.

In addition to business development, Navicor had its share of innovation with long-term clients. For four years running, the agency has been producing monumental attention-getting traffic builders for Seattle Genetics. The work started with an 8-foot sculpture of the company’s molecule built from 85,000 Lego pieces to life-size balloon and tuna-fish can structures to this year’s kinetic sculpture.

“I can say this is, without a doubt, our most inspired traffic builder to date,” says Katherine Winkel, product manager. “It’s a unique and mesmerizing representation of our product that will facilitate great conversations in the booth and garner significant attention from HCPs and the media about the continued innovation offered by Seattle Genetics.”

For NanoString, Navicor deployed a responsive-design Website for the global launch of its PAM50-based breast cancer diagnostic, Prosigna. “As more and more oncologists leverage mobile devices for disease and product information and consultation, responsive design enhances the effectiveness of communication while being mindful of the regulatory constraints of the pharmaceutical industry,” says Dylan Menges, digital creative director.

With initiatives ranging from Web deployment to personal selling, digital continues to be a key and expanding expertise for Navicor. “We have fostered relationships with Google and Microsoft to offer unique solutions otherwise not available to clients,” executives say.

For Teva Pharmaceutical Industries, Navicor produced a disease education channel on YouTube, called Mechanisms of Resistance in Tumors (MERIT) that showcases four unique infographic videos.

For Cadence, Navicor worked with inVentiv Digital, iQ Labs, and Microsoft to produce a first-in-class interactive visual aid for the Microsoft Surface Pro.

Structure And Services

Early this year, Dezember was promoted to CEO. Querry was promoted to president and is leading the day-to-day activity of the agency. Marvin J. Bowe III was promoted to chief operating officer; Richard D’Ginto was promoted to senior VP, executive creative director; and Damon Owens was promoted to senior VP, strategic services.

Future Plans

Agency leaders say Navicor will continue its focus in oncology, but it is more than just promoting cancer therapies.

According to Dezember, “From our inception, oncology was more of an overall business platform for us to leverage throughout the market. We are branching beyond therapeutics into diagnostics, supportive care, patient outreach, and managed care, to name a few – all with single-mindedness toward lending our unique communications expertise in cancer.”

In addition, Navicor continues to look toward opportunities to expand its offices to additional geographic locations.

Philanthropy/Citizenship

With its focus on oncology, Navicor continued its long-standing relationship with organizations such as The Leukemia & Lymphoma Society and fostered new relationships with groups such as American Cancer Society. This year, Bowe designed the memorabilia pin logo for the ACS Philadelphia chapter’s Bike-a-thon. “I have participated in the ride to raise money for several years, but it was even more rewarding to offer Navicor’s creative services to help advance the ACS cause,” Bowe says.